{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T22:59:25Z","timestamp":1774306765582,"version":"3.50.1"},"reference-count":121,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Paraneoplastic dermatoses (PDs) belong to a group of rare and polymorphous dermatoses, and they can often be the first sign of underlying malignancies. Therefore, dermatologists should be able to identify skin features to identify earlier underlying neoplasms. Indeed, lack of familiarity with cutaneous clues of internal malignancies can lead to a delay in the diagnosis and an impairment of the prognosis of the patients. In this review, we described several PDs, including more common and rarer PD. Indeed, while malignant acanthosis nigricans, characterized by velvety, verrucous, hyperpigmented plaques that usually affect intertriginous areas, is a well-known PD, necrolytic migratory erythema is usually misdiagnosed because its clinical features can be similar to seborrheic dermatitis. Furthermore, we focused on two paradigmatic PDs, namely paraneoplastic autoimmune multiorgan syndrome (PAMS) and paraneoplastic dermatomyositis. Indeed, PAMS represents a paradigmatic form of obligate PD, which is always associated with an underlying neoplasm, while paraneoplastic dermatomyositis belongs to the facultative PD, which can be associated with neoplasia in a variable percentage of cases.<\/jats:p>","DOI":"10.3390\/jcm14031014","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T10:09:52Z","timestamp":1738750192000},"page":"1014","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Paraneoplastic Dermatoses: A Clue for Underlying Malignancies"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6119-1870","authenticated-orcid":false,"given":"Dario","family":"Didona","sequence":"first","affiliation":[{"name":"Rare Diseases Unit, Istituto Dermopatico dell\u2019Immacolata (IDI)-IRCCS, 00167 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Rallo","sequence":"additional","affiliation":[{"name":"Rare Diseases Unit, Istituto Dermopatico dell\u2019Immacolata (IDI)-IRCCS, 00167 Rome, Italy"},{"name":"Dermatology Unit, Department of Clinical Internal, Anesthesiological and Cardiovascular Science, University of La Sapienza, 00185 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8231-2205","authenticated-orcid":false,"given":"Andrea","family":"Carugno","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Department of Medicine and Surgery, University of Insubria, 21100 Varese, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Paolino","sequence":"additional","affiliation":[{"name":"Unit of Dermatology, IRCCS Ospedale San Raffaele, 20132 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Didona, D., Fania, L., Didona, B., Eming, R., Hertl, M., and Di Zenzo, G. (2020). Paraneoplastic Dermatoses: A Brief General Review and an Extensive Analysis of Paraneoplastic Pemphigus and Paraneoplastic Dermatomyositis. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21062178"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00108-018-0548-5","article-title":"Seltene Erkrankungen an der Haut erkennen","volume":"60","author":"Gualtieri","year":"2019","journal-title":"Internist"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1590\/S0365-05962013000100001","article-title":"Paraneoplastic cutaneous manifestations: Concepts and updates","volume":"88","author":"Mesquita","year":"2013","journal-title":"An. Bras. Dermatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1111\/jdv.13752","article-title":"Glucagonoma syndrome: A review and update on treatment","volume":"30","author":"John","year":"2016","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1097\/DAD.0000000000001219","article-title":"Glucagonoma-Associated Necrolytic Migratory Erythema: The Broad Spectrum of the Clinical and Histopathological Findings and Clues to the Diagnosis","volume":"41","author":"Toberer","year":"2019","journal-title":"Am. J. Dermatopathol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Albers, M.B., Sevcik, M., Wiese, D., Manoharan, J., Rinke, A., Jesinghaus, M., and Bartsch, D.K. (2024). Characteristics, therapy, and outcome of rare functioning pancreatic neuroendocrine neoplasms. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-68290-1"},{"key":"ref_7","first-page":"784","article-title":"\u201cCutaneous manifestations of internal malignant tumors\u201d by Becker, Kahn and Rothman, June 1942. Commentary: Migratory necrolytic erythema","volume":"118","author":"Braverman","year":"1982","journal-title":"Arch. Dermatol."},{"key":"ref_8","first-page":"1197","article-title":"Necrolytic migratory erythema with pancreatic carcinoma","volume":"64","author":"Wilkinson","year":"1971","journal-title":"Proc. R. Soc. Med."},{"key":"ref_9","first-page":"4","article-title":"Etiology and pathogenesis of necrolytic migratory erythema: Review of the literature","volume":"6","author":"Tierney","year":"2004","journal-title":"MedGenMed"},{"key":"ref_10","first-page":"531","article-title":"The glucagonoma syndrome and necrolytic migratory erythema: A clinical review","volume":"151","author":"Lips","year":"2004","journal-title":"Eur. J. Endocrinol."},{"key":"ref_11","first-page":"179","article-title":"Glucagonoma and pseudoglucagonoma syndrome","volume":"5","year":"2004","journal-title":"JOP"},{"key":"ref_12","first-page":"248","article-title":"Rare presentation of endocrine pancreatic tumour: A case of glucagonoma without necrolytic migratory erythema?","volume":"27","author":"Manes","year":"1995","journal-title":"Ital. J. Gastroenterol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00005792-198003000-00002","article-title":"Clinical and metabolic aspects of glucagonoma","volume":"59","author":"Leichter","year":"1980","journal-title":"Medicine"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"101130","DOI":"10.1016\/j.currproblcancer.2024.101130","article-title":"Management of functional neuroendocrine tumors","volume":"52","author":"Wahba","year":"2024","journal-title":"Curr. Probl. Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0738-081X(00)00150-4","article-title":"Acrodermatitis enteropathica","volume":"18","author":"Sehgal","year":"2000","journal-title":"Clin. Dermatol."},{"key":"ref_16","first-page":"1188","article-title":"Pemphigus and pemphigoids: Clinical presentation, diagnosis and therapy","volume":"21","author":"Didona","year":"2023","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0738-081X(93)90060-P","article-title":"The red face: Seborrheic dermatitis","volume":"11","author":"Rebora","year":"1993","journal-title":"Clin. Dermatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1056\/NEJM199012203232503","article-title":"Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia","volume":"323","author":"Anhalt","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1365-2133.1974.tb06424.x","article-title":"The association of pemphigus with thymoma or malignancy: A critical review","volume":"90","author":"Krain","year":"1974","journal-title":"Br. J. Dermatol."},{"key":"ref_20","first-page":"193","article-title":"Classification, clinical manifestations, and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: A reappraisal of paraneoplastic pemphigus","volume":"137","author":"Nguyen","year":"2001","journal-title":"Arch. Dermatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2023.08.020","article-title":"Paraneoplastic pemphigus\/paraneoplastic autoimmune multiorgan syndrome: Part I. Clinical overview and pathophysiology","volume":"91","author":"Anderson","year":"2024","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.oraloncology.2003.09.020","article-title":"Neoplasms associated with paraneoplastic pemphigus: A review with emphasis on non-hematologic malignancy and oral mucosal manifestations","volume":"40","author":"Kaplan","year":"2004","journal-title":"Oral Oncol."},{"key":"ref_23","first-page":"174","article-title":"Paraneoplastic autoimmune multiorgan syndrome","volume":"156","author":"Didona","year":"2021","journal-title":"Ital. J. Dermatol. Venerol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00105-021-04773-w","article-title":"Paraneoplastische Autoimmundermatosen","volume":"72","author":"Didona","year":"2021","journal-title":"Hautarzt"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1093\/oxfordjournals.annonc.a059294","article-title":"Lethal paraneoplastic pemphigus following treatment of chronic lymphocytic leukaemia with fludarabine","volume":"6","author":"Bazarbachi","year":"1995","journal-title":"Ann. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1046\/j.1365-2133.2001.04244.x","article-title":"Paraneoplastic pemphigus: An association with fludarabine?","volume":"144","author":"Gooptu","year":"2001","journal-title":"Br. J. Dermatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1468-3083.2004.00917.x","article-title":"Paraneoplastic pemphigus secondary to fludarabine evolving into unusual oral pemphigus vegetans","volume":"18","author":"Powell","year":"2004","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF02685912","article-title":"Paraneoplastic pemphigus associated with fludarabine use","volume":"24","author":"Yildiz","year":"2007","journal-title":"Med. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1365-2133.1995.tb08688.x","article-title":"Treatment with alpha interferon associated with the development of paraneoplastic pemphigus","volume":"132","author":"Kirsner","year":"1995","journal-title":"Br. J. Dermatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/0190-9622(93)70244-N","article-title":"Paraneoplastic pemphigus appearing as bullous pemphigoid-like eruption after palliative radiation therapy","volume":"29","author":"Fried","year":"1993","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1440-0960.1995.tb00976.x","article-title":"Paraneoplastic pemphigus triggered by radiotherapy","volume":"36","author":"Lee","year":"1995","journal-title":"Australas. J. Dermatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0896-8411(02)00092-6","article-title":"Paraneoplastic pemphigus is associated with the DRB1*03 allele","volume":"20","author":"Martel","year":"2003","journal-title":"J. Autoimmun."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1365-2133.2007.08361.x","article-title":"Genotyping of HLA-I and HLA-II alleles in Chinese patients with paraneoplastic pemphigus","volume":"158","author":"Liu","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.autrev.2018.04.008","article-title":"Paraneoplastic autoimmune multiorgan syndrome (PAMS): Beyond the single phenotype of paraneoplastic pemphigus","volume":"17","author":"Amber","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1046\/j.1365-2133.2001.04095.x","article-title":"Paraneoplastic pemphigus without antidesmoglein 3 or antidesmoglein 1 autoantibodies","volume":"144","author":"Inaoki","year":"2001","journal-title":"Br. J. Dermatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1172\/JCI3647","article-title":"Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice","volume":"102","author":"Amagai","year":"1998","journal-title":"J. Clin. Investig."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Paolino, G., Didona, D., Magliulo, G., Iannella, G., Didona, B., Mercuri, S.R., Moliterni, E., Donati, M., Ciofalo, A., and Granata, G. (2017). Paraneoplastic Pemphigus: Insight into the Autoimmune Pathogenesis, Clinical Features and Therapy. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18122532"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1378\/chest.117.2.603","article-title":"Paraneoplastic pemphigus associated with bronchiolitis obliterans","volume":"117","author":"Takahashi","year":"2000","journal-title":"Chest"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/JID.2015.408","article-title":"Epiplakin Is a Paraneoplastic Pemphigus Autoantigen and Related to Bronchiolitis Obliterans in Japanese Patients","volume":"136","author":"Tsuchisaka","year":"2016","journal-title":"J. Investig. Dermatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1111\/bjd.14162","article-title":"Clinical and immunological findings in 104 cases of paraneoplastic pemphigus","volume":"173","author":"Ohzono","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/bjd.13525","article-title":"Prevalence of myasthenia gravis and associated autoantibodies in paraneoplastic pemphigus and their correlations with symptoms and prognosis","volume":"172","author":"Wang","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.det.2011.03.018","article-title":"Paraneoplastic pemphigus (paraneoplastic autoimmune multiorgan syndrome): Clinical presentations and pathogenesis","volume":"29","author":"Frew","year":"2011","journal-title":"Dermatol. Clin."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/jdv.18931","article-title":"S2k guidelines on the management of paraneoplastic pemphigus\/paraneoplastic autoimmune multiorgan syndrome initiated by the European Academy of Dermatology and Venereology (EADV)","volume":"37","author":"Antiga","year":"2023","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1067\/mjd.2000.107488","article-title":"Sensitivity and specificity of clinical, histologic, and immunologic features in the diagnosis of paraneoplastic pemphigus","volume":"43","author":"Joly","year":"2000","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/1523-1747.ep12607012","article-title":"Characterization of paraneoplastic pemphigus autoantigens by immunoblot analysis","volume":"104","author":"Hashimoto","year":"1995","journal-title":"J. Investig. Dermatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cca.2009.08.022","article-title":"Development of ELISA for the specific determination of autoantibodies against envoplakin and periplakin in paraneoplastic pemphigus","volume":"410","author":"Probst","year":"2009","journal-title":"Clin. Chim. Acta"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jaad.2023.08.084","article-title":"Paraneoplastic pemphigus\/paraneoplastic autoimmune multiorgan syndrome: Part II. Diagnosis and management","volume":"91","author":"Huang","year":"2024","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1038\/jid.2012.1","article-title":"Differential IgG recognition of desmoglein 3 by paraneoplastic pemphigus and pemphigus vulgaris sera","volume":"132","author":"Brandt","year":"2012","journal-title":"J. Investig. Dermatol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1046\/j.1365-2133.2002.04992.x","article-title":"Paraneoplastic pemphigus in children and adolescents","volume":"147","author":"Mimouni","year":"2002","journal-title":"Br. J. Dermatol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1001\/archderm.1993.01680280071014","article-title":"Paraneoplastic pemphigus is a distinct neoplasia-induced autoimmune disease","volume":"129","author":"Camisa","year":"1993","journal-title":"Arch. Dermatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1468-3083.2005.01345.x","article-title":"Therapy of paraneoplastic pemphigus with Rituximab: A case report and review of literature","volume":"20","author":"Barnadas","year":"2006","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1056\/NEJMicm2104582","article-title":"Tripe Palms","volume":"387","author":"Boyce","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00108-019-0636-1","article-title":"Paraneoplastische Hauterkrankungen","volume":"60","author":"Khoschbin","year":"2019","journal-title":"Internist"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"5632","DOI":"10.12998\/wjcc.v8.i22.5632","article-title":"Malignant acanthosis nigricans with Leser-Tr\u00e9lat sign and tripe palms: A case report","volume":"8","author":"Wang","year":"2020","journal-title":"World J. Clin. Cases"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1159\/000511251","article-title":"Diffuse Esophageal Squamous Papillomatosis: A Rare Disease Associated with Acanthosis Nigricans and Tripe Palms","volume":"14","author":"Chantarojanasiri","year":"2020","journal-title":"Case Rep. Gastroenterol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.det.2007.08.008","article-title":"Epidermal manifestations of internal malignancy","volume":"26","author":"Moore","year":"2008","journal-title":"Dermatol. Clin."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00105-021-04777-6","article-title":"Hyperplasie-assoziierte obligate Paraneoplasien der Haut","volume":"72","author":"Schmidt","year":"2021","journal-title":"Hautarzt"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1046\/j.1365-2133.1998.02190.x","article-title":"Tripe palms associated with systemic mastocytosis: The role of transforming growth factor-alpha and efficacy of interferon-alfa","volume":"138","author":"Chosidow","year":"1998","journal-title":"Br. J. Dermatol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11684-013-0246-6","article-title":"Primary hypertrophic osteoarthropathy: An update","volume":"7","author":"Zhang","year":"2013","journal-title":"Front. Med."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Butacu, A.-I., Toma, C., Negulet, I.-E., Manole, I., Banica, A.N., Plesea, A., Badircea, I.A., Iancu, I., and Tiplica, G.-S. (2024). Updates on Psoriasis in Special Areas. J. Clin. Med., 13.","DOI":"10.3390\/jcm13247549"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1111\/jocd.13544","article-title":"Acanthosis nigricans: A review","volume":"19","author":"Das","year":"2020","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1684\/ejd.2013.2232","article-title":"Paraneoplastic acanthosis nigricans paralleling disease course in a patient with mycosis fungoides","volume":"23","author":"Chong","year":"2013","journal-title":"Eur. J. Dermatol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5070\/D3217028120","article-title":"A case of acanthosis nigricans coexisting with mycosis fungoides","volume":"21","author":"Cheng","year":"2015","journal-title":"Dermatol. Online J."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0190-9622(88)70257-1","article-title":"Acanthosis nigricans associated with mycosis fungoides","volume":"19","author":"Schweitzer","year":"1988","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jdcr.2021.08.032","article-title":"A case of acanthosis nigricans-like mycosis fungoides","volume":"16","author":"Kim","year":"2021","journal-title":"JAAD Case Rep."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/cup.14405","article-title":"T follicular helper phenotype mycosis fungoides associated with acanthosis nigricans","volume":"50","author":"Spigariolo","year":"2023","journal-title":"J. Cutan. Pathol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4103\/idoj.idoj_424_23","article-title":"Terra Firma-Forme Dermatosis-More Than Just Dirty","volume":"15","author":"Mohta","year":"2024","journal-title":"Indian Dermatol. Online J."},{"key":"ref_68","first-page":"51","article-title":"The Leser-Tr\u00e9lat Sign in a Patient with Gastric Adenocarcinoma","volume":"31","author":"Geber","year":"2023","journal-title":"Acta Dermatovenerol. Croat."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5070\/D3231033672","article-title":"Cutaneous T-cell lymphoma-associated Leser-Tr\u00e9lat sign: Report and world literature review","volume":"23","author":"Narala","year":"2017","journal-title":"Dermatol. Online J."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e228834","DOI":"10.1136\/bcr-2018-228834","article-title":"Leser-Tr\u00e9lat sign in metastatic melanoma to pleura","volume":"12","author":"Pereira","year":"2019","journal-title":"BMJ Case Rep."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"918","DOI":"10.3949\/ccjm.84a.17021","article-title":"The Leser-Tr\u00e9lat sign","volume":"84","author":"Sardon","year":"2017","journal-title":"Cleve. Clin. J. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"8665","DOI":"10.4081\/dr.2020.8665","article-title":"Leser-Tr\u00e9lat sign as a rare manifestation of cutaneous melanoma","volume":"12","author":"Gori","year":"2020","journal-title":"Dermatol. Rep."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000471787","article-title":"Eruptive Seborrheic Keratoses Restricted to Plaque\/Patch-Stage Mycosis Fungoides","volume":"9","author":"Lebas","year":"2017","journal-title":"Case Rep. Dermatol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/j.1365-4632.2009.03766.x","article-title":"Detection of high-risk human papillomaviruses in verrucae of patients with mycosis fungoides and S\u00e9zary syndrome: A case series","volume":"48","author":"Vidulich","year":"2009","journal-title":"Int. J. Dermatol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1365-2230.1996.tb00017.x","article-title":"Mycosis fungoides associated with unusual epidermal hyperplasia","volume":"21","author":"Puig","year":"1996","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1097\/AOG.0000000000002920","article-title":"The Sign of Leser-Trel\u00e1t and Malignant Acanthosis Nigricans Associated with Fallopian Tube Carcinoma","volume":"132","author":"West","year":"2018","journal-title":"Obstet. Gynecol."},{"key":"ref_77","first-page":"e35155","article-title":"The Pseudo-Sign of Leser-Tr\u00e9lat: A Rare Presentation","volume":"15","author":"Suening","year":"2023","journal-title":"Cureus"},{"key":"ref_78","first-page":"565","article-title":"Inflammation of seborrheic keratoses caused by cytarabine: A pseudo sign of Leser-Trelat","volume":"3","author":"Patton","year":"2004","journal-title":"J. Drugs Dermatol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"e7638","DOI":"10.1002\/ccr3.7638","article-title":"COVID-19 infection and Leser-Trelat sign: Is there an association?","volume":"11","author":"Handjani","year":"2023","journal-title":"Clin. Case Rep."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/j.1365-2230.2004.01576.x","article-title":"Transient eruptive seborrhoeic keratoses associated with erythrodermic pityriasis rubra pilaris","volume":"29","author":"Sahin","year":"2004","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1468-3083.2008.02799.x","article-title":"Eruptive seborrhoeic keratoses associated with erythrodermic pityriasis rubra pilaris","volume":"23","author":"Gleeson","year":"2009","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1365-4362.1994.tb02864.x","article-title":"Lepromatous leprosy with extensive truncal seborrheic keratoses and acral verruca vulgaris","volume":"33","author":"Garg","year":"1994","journal-title":"Int. J. Dermatol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1046\/j.1365-2133.2003.05463.x","article-title":"Eruptive seborrhoeic keratosis in human immunodeficiency virus infection: A coincidence or \u2018the sign of Leser-Tr\u00e9lat\u2019?","volume":"149","author":"Inamadar","year":"2003","journal-title":"Br. J. Dermatol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1684\/ejd.2020.3761","article-title":"The polymorphous spectrum of dermatomyositis: Classic features, newly described skin lesions, and rare variants","volume":"30","author":"Didona","year":"2020","journal-title":"Eur. J. Dermatol."},{"key":"ref_85","first-page":"84","article-title":"Dermatomyositis: A comprehensive review of clinical manifestations, serological features, and therapeutic approaches","volume":"158","author":"Didona","year":"2023","journal-title":"Ital. J. Dermatol. Venerol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1007\/s00296-023-05283-9","article-title":"A systematic review of the incidence, management and prognosis of new-onset autoimmune connective tissue diseases after COVID-19","volume":"43","author":"Kouranloo","year":"2023","journal-title":"Rheumatol. Int."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(99)05157-0","article-title":"Dermatomyositis","volume":"355","author":"Callen","year":"2000","journal-title":"Lancet"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s11926-024-01164-7","article-title":"Recent Updates on the Pathogenesis of Inflammatory Myopathies","volume":"26","author":"Musai","year":"2024","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N. Engl. J. Med."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis (second of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N. Engl. J. Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s12016-017-8652-1","article-title":"Cutaneous Manifestations of Dermatomyositis: A Comprehensive Review","volume":"53","author":"Mainetti","year":"2017","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"e9639","DOI":"10.1097\/MD.0000000000009639","article-title":"Evidence supports blind screening for internal malignancy in dermatomyositis: Data from 2 large US dermatology cohorts","volume":"97","author":"Leatham","year":"2018","journal-title":"Medicine"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Requena, C., S\u00e1nchez-Romero, E., Nagore, E., and Sanmart\u00edn, O. (2024). Dermatomiositis paraneopl\u00e1sica: Una serie de 25 casos de un hospital oncol\u00f3gico. Actas Dermosifiliogr.","DOI":"10.1016\/j.ad.2024.04.030"},{"key":"ref_94","first-page":"354","article-title":"Dermatomyositis-Part 2: Diagnosis, Association with Malignancy, and Treatment","volume":"14","author":"Pirmez","year":"2016","journal-title":"Skinmed"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/archderm.138.7.969","article-title":"When and how should the patient with dermatomyositis or amyopathic dermatomyositis be assessed for possible cancer?","volume":"138","author":"Callen","year":"2002","journal-title":"Arch. Dermatol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1054\/bjoc.2001.1699","article-title":"Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: A Scottish population-based cohort study","volume":"85","author":"Stockton","year":"2001","journal-title":"Br. J. Cancer"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/1756-185X.14046","article-title":"Risk factors for cancer-associated myositis: A large-scale multicenter cohort study","volume":"24","author":"Li","year":"2021","journal-title":"Int. J. Rheum. Dis."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1684\/ejd.2020.3766","article-title":"Amyopathic and anti-TIF1 gamma-positive dermatomyositis: Analysis of a monocentric cohort and proposal to update diagnostic criteria","volume":"30","author":"Didona","year":"2020","journal-title":"Eur. J. Dermatol."},{"key":"ref_99","first-page":"586","article-title":"Shiitake dermatosis in a Caucasian woman","volume":"153","author":"Didona","year":"2018","journal-title":"G. Ital. Dermatol. Venereol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41572-020-0213-x","article-title":"Pyoderma gangrenosum","volume":"6","author":"Maverakis","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.det.2023.12.005","article-title":"Pediatric Neutrophilic Dermatoses","volume":"42","author":"Torrelo","year":"2024","journal-title":"Dermatol. Clin."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jaad.2019.08.001","article-title":"Prevalence estimates for pyoderma gangrenosum in the United States: An age- and sex-adjusted population analysis","volume":"83","author":"Xu","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"e39634","DOI":"10.1097\/MD.0000000000039634","article-title":"Clinical characteristics of pyoderma gangrenosum: Case series and literature review","volume":"103","author":"Su","year":"2024","journal-title":"Medicine"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s40257-017-0251-7","article-title":"Pyoderma Gangrenosum: An Update on Pathophysiology, Diagnosis and Treatment","volume":"18","author":"Alavi","year":"2017","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Maronese, C.A., Derlino, F., Moltrasio, C., Cattaneo, D., Iurlo, A., and Marzano, A.V. (2023). Neutrophilic and eosinophilic dermatoses associated with hematological malignancy. Front. Med., 10.","DOI":"10.3389\/fmed.2023.1324258"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s40257-020-00553-9","article-title":"Immune-Mediated Dermatoses in Patients with Haematological Malignancies: A Comprehensive Review","volume":"21","author":"Maglie","year":"2020","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/ijd.14637","article-title":"Paraneoplastic pyoderma gangrenosum in solid organ malignancy: A literature review","volume":"59","author":"Shah","year":"2020","journal-title":"Int. J. Dermatol."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"\u0141yko, M., Rygu\u0142a, A., Kowalski, M., Karska, J., and Jankowska-Konsur, A. (2024). The Pathophysiology and Treatment of Pyoderma Gangrenosum-Current Options and New Perspectives. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25042440"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2174\/138920210793175921","article-title":"Clinical, Molecular, and Genetic Characteristics of PAPA Syndrome: A Review","volume":"11","author":"Smith","year":"2010","journal-title":"Curr. Genom."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.celrep.2015.12.072","article-title":"Neutrophil-Derived Proteases Escalate Inflammation through Activation of IL-36 Family Cytokines","volume":"14","author":"Henry","year":"2016","journal-title":"Cell Rep."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.cell.2010.03.002","article-title":"Autoinflammatory disease reloaded: A clinical perspective","volume":"140","author":"Kastner","year":"2010","journal-title":"Cell"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/1744666X.2018.1438269","article-title":"Pyoderma gangrenosum: A review of pathogenesis and treatment","volume":"14","author":"Ahn","year":"2018","journal-title":"Expert Rev. Clin. Immunol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jaad.2016.06.016","article-title":"Clinical outcomes and response of patients applying topical therapy for pyoderma gangrenosum: A prospective cohort study","volume":"75","author":"Thomas","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1365-2133.1964.tb14541.x","article-title":"An Acute Febrile Neutrophilic Dermatosis","volume":"76","author":"Sweet","year":"1964","journal-title":"Br. J. Dermatol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1750-1172-2-34","article-title":"Sweet\u2019s syndrome\u2014A comprehensive review of an acute febrile neutrophilic dermatosis","volume":"2","author":"Cohen","year":"2007","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Calabrese, L., Satoh, T.K., Aoki, R., Rubegni, G., Neulinger-M\u0169noz, M., Stadler, P.C., French, L.E., and Rubegni, P. (2024). Sweet syndrome: An update on clinical aspects, pathophysiology, and treatment. Ital. J. Dermatol. Venerol.","DOI":"10.23736\/S2784-8671.24.07956-8"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1200\/JCO.1988.6.12.1887","article-title":"Malignancy-associated Sweet\u2019s syndrome: Review of the world literature","volume":"6","author":"Cohen","year":"1988","journal-title":"J. Clin. Oncol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/0002-9343(87)90229-4","article-title":"Sweet\u2019s syndrome and malignancy","volume":"82","author":"Cohen","year":"1987","journal-title":"Am. J. Med."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1159\/000535399","article-title":"Acute Febrile Neutrophilic Dermatosis (Sweet Syndrome) in Acute Myeloid Leukemia Patients: A 28-Year Institutional Experience","volume":"147","author":"Cowen","year":"2024","journal-title":"Acta Haematol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/cei.12394","article-title":"Expression of cytokines, chemokines and other effector molecules in two prototypic autoinflammatory skin diseases, pyoderma gangrenosum and Sweet\u2019s syndrome","volume":"178","author":"Marzano","year":"2014","journal-title":"Clin. Exp. Immunol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1159\/000530519","article-title":"Sweet Syndrome: A Review of Published Cases","volume":"239","author":"Orfaly","year":"2023","journal-title":"Dermatology"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/3\/1014\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:27:27Z","timestamp":1760027247000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/3\/1014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,5]]},"references-count":121,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["jcm14031014"],"URL":"https:\/\/doi.org\/10.3390\/jcm14031014","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,5]]}}}